Affiliation:
1. The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital
2. Nantong University
3. The Hong Kong Polytechnic University
4. Jiangsu University of Science and Technology
Abstract
Abstract
Objective: This study aimed to develop a prediction model for esophageal fistula (EF) in esophageal cancer (EC) patients treated with intensity-modulated radiation therapy (IMRT), by integrating multi-omics features from multiple volumes-of-interest (VOIs).
Methods: We retrospectively analyzed pretreatment planning computed tomographic (CT) images, three-dimensional dose distributions, and clinical factors of 287 EC patients. Nine groups of features from different combination of omics [Radiomics (R), Dosiomics (D), and RD (the combination of R and D)], and VOIs [esophagus (ESO), gross tumor volume (GTV), and EG (the combination of ESO and GTV)] were extracted and separately selected by unsupervised and supervised approaches. The final model performance was evaluated using five metrics: average area under the receiver-operator-characteristics curve (AUC), accuracy, precision, recall, and F1-score.
Results: For multi-omics using RD features, the model performance in EG model shows:AUC, 0.817±0.031; 95% CI: 0.805, 0.825; p<0.001, which is better than single VOI (ESO or GTV).
Conclusion: Integrating multi-omics features from multi-VOIs enables better prediction of EF in EC patients treated with IMRT. The incorporation of dosiomics features can enhance the model performance of the prediction.
Publisher
Research Square Platform LLC
Reference48 articles.
1. Curini L, Christopher MR, Grubitzsch H, et al. Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS 2021.
2. Emerging multimodality approaches to treat localized esophageal cancer;Kelly RJ;JNCCN Journal of the National Comprehensive Cancer Network,2019
3. Recent progress in multidisciplinary treatment for patients with esophageal cancer;Watanabe M;Surgery Today,2020
4. Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology;Ajani JA;Journal of the National Comprehensive Cancer Network,2019
5. Advances in the treatment of gastric cancer: 2020–2021;Ilson DH;Current opinion in gastroenterology,2021